Ultrasound Guided Adductor Canal Block for Postoperative Pain Relief after Total Knee Arthroplasty with Levobupivacaine versus Levobupivacaine with Dexmeditomedine: A Randomized Clinical Study
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.46 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Kishore Keerthy N und 3 weiteren Autor:innen.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Effective post-operative analgesia is crucial for enhancing recovery and reducing opioid requirements in patients undergoing total knee arthroplasty (TKR). Levobupivacaine is a commonly used local anaesthetic in adductor canal blocks (ACB) for TKR; however, its duration of analgesia can be limited. Dexmedetomidine, an alpha-2 adrenergic agonist, is recognized for its analgesic properties and potential to extend the effects of local anaesthetics. This study evaluates the effectiveness of Levobupivacaine versus Levobupivacaine combined with Dexmedetomidine in enhancing analgesic duration and quality in patients undergoing total knee arthroplasty.
Objectives
This study aimed to assess the duration of analgesia, 24-hour opioid consumption, success of early ambulation, patient satisfaction, and to look for any adverse effects or complications in patients receiving Levobupivacaine versus Levobupivacaine with Dexmedetomidine in ACB after total knee arthroplasty.
Methods
A prospective, randomized clinical trial was conducted among a total of 100 patients with two patient groups undergoing TKA. Patients undergoing elective TKR surgeries, aged between 18 and 70 years of age and categorized under American Society of Anesthesiologists (ASA) class 1 to 3 were included in this study. Group A (50 patients) received Levobupivacaine alone in ACB, while Group B (50 patients) received a combination of Levobupivacaine with Dexmedetomidine. Heart rate and blood pressure were monitored at baseline, every 15 minutes for the first hour, then at 2, 5, 12, and 24 hours post-operatively. Quadriceps power was recorded preoperatively and at 6, 12, and 24 hours after the block. Patient satisfaction and any adverse events were noted at 24 hours. Rescue analgesia was provided with 75 mg diclofenac or 100 mg tramadol with 4 mg ondansetron intravenously, and total 24-hour requirements for tramadol and diclofenac were documented. The data was collected were tabulated using Microsoft excel sheet and was analyzed in SPSS trial version 23.0 using chi-square test or Fishers exact test. p
Zitieren
APA
N, K. K., N, V. C., S, S. H., & Jojy, N. (2026). Ultrasound Guided Adductor Canal Block for Postoperative Pain Relief after Total Knee Arthroplasty with Levobupivacaine versus Levobupivacaine with Dexmeditomedine: A Randomized Clinical Study. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.46
Vancouver
N KK, N VC, S SH, Jojy N. Ultrasound Guided Adductor Canal Block for Postoperative Pain Relief after Total Knee Arthroplasty with Levobupivacaine versus Levobupivacaine with Dexmeditomedine: A Randomized Clinical Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.46
BibTeX
@article{N2026,
author = {N, Kishore Keerthy and N, Vinod C. and S, Sarala H. and Jojy, Noel},
title = {Ultrasound Guided Adductor Canal Block for Postoperative Pain Relief after Total Knee Arthroplasty with Levobupivacaine versus Levobupivacaine with Dexmeditomedine: A Randomized Clinical Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.46}
}
EUVIMED